Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Sep 12, 2019

30786_dirs_2019-09-12_375646ea-1150-4060-9fa6-8e6a7b0c069b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-10

Reporting Person: TUMOLO ANNETTE (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-10 Bio-Rad A Common Stock M 400 Acquired 2709.3476 Direct
2019-09-10 Bio-Rad A Common Stock F 139 $322.93 Disposed 2570.3476 Direct
2019-09-11 Bio-Rad A Common Stock M 600 Acquired 3170.3476 Direct
2019-09-11 Bio-Rad A Common Stock F 238 $326.42 Disposed 2932.3476 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-10 Restricted Stock Units $0 M 400 Disposed Bio-Rad A Common Stock (400) Direct
2019-09-11 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F4: The restricted stock units vest in five equal annual installments beginning September 11, 2016.